This is a preview of subscription content, log in via an institution to check access.
Notes
Funded by United Therapeutics Corporation.
Reference
Dean BB, et al. Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study. Drugs - Real World Outcomes : 6 Mar 2020. Available from: URL: https://doi.org/10.1007/s40801-020-00183-x
Rights and permissions
About this article
Cite this article
Healthcare costs lower with treprostinil versus selexipag for PAH. PharmacoEcon Outcomes News 849, 12 (2020). https://doi.org/10.1007/s40274-020-6663-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6663-2